On the choice of antiarrhythmic drug in patients with ventricular arrhythmia of mixed character

Background. The choice of an antiarrhythmic drug, proof of its effectiveness and safety in a short period of time in patients with non-coronary ventricular arrhythmia are the most pressing problems of practical arrhythmology. Objective. To resolve the issue of choosing an antiarrhythmic drug in patients with a mixed nature of ventricular arrhythmia, several ectopic foci, and to optimize further tactics for their management. Design and methods. Of 167 patients with ventricular arrhythmia distribution during periods of wakefulness who performed a stress test, 32 individuals with non-coronary arrhythmias of a mixed nature (by the participation of the autonomic nervous system) were selected. All patients underwent an acute pharmacological stress test with a beta-blocker. Antiarrhythmic therapy was selected under the control of multi-day ECG telemonitoring. Results. In the pretest of exercise tests, single ventricular parasystole was recorded in all 32 patients. In 3 patients, the arrhythmia persisted throughout the entire load, in 4 patients it progressed, in 25 patients the parasystole of the initial morphology disappeared, and at the peak of the load/early recovery period, arrhythmia of a different morphology appeared. Indications for drug treatment were determined for all patients with the choice of the drug after acute pharmacological tests. Then, therapy with two antiarrhythmic drugs was initiated using multi-day ECG telemonitoring, the purpose of which was to control the efficacy, safety, choice of doses and time of drug administration. On days 5–6, combination therapy was effective in 25 patients (78 %). Conclusion. With the help of stress tests, it is possible to accelerate not only the search for the cause of ventricular arrhythmia, but also the choice of a personalized method of treatment. Supplementing the examination with pharmacological tests allows predicting the result of combined antiarrhythmic therapy with a beta-blocker and a class IС drug with an anticholinergic effect.

1. Lebedev DS, Mikhailov EN, Neminuschiy NM, et al. Ventricular arrhythmias. Ventricular tachycardias and sudden cardiac death. 2020 Clinical guidelines. Russian Journal of Cardiology. 2021; 26:7: 4600. In Russian DOI:10.15829/1560-4071-2021-4600.

2. Treshkur TV. Clinical and electrocardiographic characteristics of ischemic ventricular arrhythmias. Bulletin of arrhythmology. 2002; 30:31–38. In Russian

3. Treshkur TV, Tatarinova AA, Ryngach EA. Method for predicting antiarrhythmic efficacy of myocardial revascularization surgery in patients with ischemic heart disease with ventricular arrhythmias caused by myocardial ischemia. Patent on the application № 2020133895, 14.10.2020. In Russian

4. Treshkur TV, Tulintseva TE, Tatarinova AA, et al. Ventricular arrhythmias and Holter monitoring — principles of forming a conclusion based on the results of the study. Bulletin of arrhythmology. 2018; 93:53–63. In Russian DOI 10.25760/VA-2018-93-53-63.

5. Golitsyn SP. Elimination of ventricular arrhythmias and reduction of risk of death: are the paths always in the same direction? Heart. 2006; 1:4–11. In Russian

6. Трешкур Т.В., Пармон Е.В., Овечкина М.А. Способ диагностики вагусзависимых желудочковых аритмий и оценки антиаритмической терапии с помощью холтеровского мониторирования. https://www.incart.ru/publish/learning-aids/sposob-diagnostiki-vaguszavisimyix-zheludochkovyix-aritmij/

7. Zhabina ES, Tulintseva TE, Treshkur TV. Algorithm for the management of patients with ventricular arrhythmias recorded during wakefulness. Russ J Cardiol. 2022; 27:7:5048. In Russian DOI:10.15829/1560-4071-2022-5048.

8. Shlyakhto EV, Treshkur TV, Tulintseva TE, et al. Algorithm for managing patients with ventricular arrhythmias. Terapevticheskij arxiv=Therapeutic Archive. 2015; 87:5:106–112. In Russian DOI 10.17116/terarkh2015875106-112.

9. Ryngach EA, Treshkur TV, Tatarinova AA, et al. Algorithm for the management of patients with stable ischemic heart disease and high-grade ventricular arrhythmias. Terapevticheskij arxiv=Therapeutic Archive. 2017; 89:1:94– 102. In Russian DOI: 10.17116/terarkh201789194-102.

10. Ivanova TE, Zhabina ES, Treshkur TV. A method for the treatment of non-coronary ventricular parasystole, registered at rest. Patent on the application No. 2822705, 11.07.2024. In Russian

11. Pay L, Tezen O, Çetin T, et al. The association between exercise-induced ventricular premature contractions and long-term mortality in patients without obstructive coronary artery disease. Acta Cardiol Sin. 2024; 40:3:267–274. DOI: 10.6515/ACS.202405_40(3).20231227A.

12. Gupta K, Zahedi S, Kakar T, et al. Independent prognostic value of high-risk ventricular premature complexes during exercise or recovery in asymptomatic patients: A meta-analysis of observational studies. Indian Heart J. 2023; 75:6:423–428. DOI: 10.1016/j.ihj.2023.10.001.

13. van Duijvenboden S, Ramírez J, Orini M, et al. Prognostic significance of different ventricular ectopic burdens during submaximal exercise in asymptomatic UK biobank subjects. Circulation. 2023; 148:24:1932–1944. DOI: 10.1161/CIRCULATIONAHA.123.064633.

14. Refaat M, Gharios C, Moorthy M, et al. ExerciseInduced Ventricular Ectopy and Cardiovascular Mortality in Asymptomatic Individuals. J Am Coll Cardiol. 2021; 78:23:2267–2277. DOI: 10.1016/j.jacc.2021.09.1366.